Water Snake Peptide Shows Promise Against H. Pylori Infection and Stomach Cancer

ECCT, a new cathelicidin from the Chinese water snake, inhibits H. pylori growth and shows anti-gastric cancer activity.

Qiu, Jie et al.·Microbial pathogenesis·2025·lowlaboratory
RPEP-13149Laboratorylow2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
laboratory
Evidence
low
Sample
N=N/A (in vitro study)
Participants
N/A

What This Study Found

Snake-derived ECCT peptide shows both anti-H. pylori activity and anti-gastric cancer properties.

Key Numbers

MIC determined against multiple pathogens; suppressed proinflammatory cytokine transcription; inhibited MAPK pathway.

How They Did This

cDNA cloning, phylogenetic/structural analysis, MIC determination, and anti-H. pylori and anti-cancer testing.

Why This Research Matters

H. pylori infects half the world's population and is the primary cause of gastric cancer — new treatment options are urgently needed.

The Bigger Picture

Snake venom and secretion peptides continue to yield promising drug leads, adding to antimicrobial and anticancer peptide libraries.

What This Study Doesn't Tell Us

In vitro study — bioavailability, stability in gastric acid, and in vivo efficacy need assessment.

Questions This Raises

  • ?Could ECCT survive the acidic stomach environment to reach H. pylori?
  • ?Is the anti-cancer effect direct or mediated through H. pylori clearance?

Trust & Context

Key Stat:
Dual action ECCT shows both anti-H. pylori antimicrobial activity and anti-gastric cancer properties
Evidence Grade:
In vitro discovery study — identifies a promising candidate but far from clinical application.
Study Age:
Published in 2025, expanding the antimicrobial peptide arsenal against H. pylori.
Original Title:
Novel antimicrobial peptide ECCT from Chinese water snake is a potential candidate for the treatment of Helicobacter pylori infection and gastric cancer.
Published In:
Microbial pathogenesis, 206, 107821 (2025)
Database ID:
RPEP-13149

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Can snake peptides treat stomach infections?

ECCT from the Chinese water snake kills H. pylori in lab tests and shows anti-cancer activity, but human studies are needed.

Why look to snakes for new antibiotics?

Reptiles produce diverse antimicrobial peptides as part of their immune system — these are largely unexplored as drug sources.

Read More on RethinkPeptides

Cite This Study

RPEP-13149·https://rethinkpeptides.com/research/RPEP-13149

APA

Qiu, Jie; Shi, Wenzhuang; Qian, Zhenghai; Zhang, Pengyu; Li, Shuangyu; Shen, Genhai; Wang, Yipeng; Li, Bin. (2025). Novel antimicrobial peptide ECCT from Chinese water snake is a potential candidate for the treatment of Helicobacter pylori infection and gastric cancer.. Microbial pathogenesis, 206, 107821. https://doi.org/10.1016/j.micpath.2025.107821

MLA

Qiu, Jie, et al. "Novel antimicrobial peptide ECCT from Chinese water snake is a potential candidate for the treatment of Helicobacter pylori infection and gastric cancer.." Microbial pathogenesis, 2025. https://doi.org/10.1016/j.micpath.2025.107821

RethinkPeptides

RethinkPeptides Research Database. "Novel antimicrobial peptide ECCT from Chinese water snake is..." RPEP-13149. Retrieved from https://rethinkpeptides.com/research/qiu-2025-novel-antimicrobial-peptide-ecct

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.